Cost-Utility of Antimicrobial Prophylaxis for Treatment of Children With Vesicoureteral Reflux

Association of Renal Scarring With Number of Febrile Urinary Tract Infections in Children

(2019) Nader Shaikh et al.   JAMA Pediatrics

History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease

(2018) Ronit Calderon-Margalit et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vesicoureteral reflux is a phenotype, not a disease: A population-centered approach to pediatric urinary tract infection

(2017) Jathin Bandari et al.   Journal of Pediatric Urology

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

(2016) Gillian D. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antimicrobial Prophylaxis for Children with Vesicoureteral Reflux

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Quality of Life of Young Adults and Adolescents with Chronic Kidney Disease

(2013) Allison Tong et al.   JOURNAL OF PEDIATRICS

Medical Costs of CKD in the Medicare Population

(2013) A. A. Honeycutt et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Urinary tract infections in children and the risk of ESRF

(2011) Jeff Round et al.   ACTA PAEDIATRICA

Association Between Clinical Risk Factors and Progression of Chronic Kidney Disease in Children

(2010) A. O. Staples et al.   Clinical Journal of the American Society of Nephrology

What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

(2009) R Scott Braithwaite et al.   MEDICAL CARE